Displaying items by tag: research agreement

Biotechnology company Cartherics, which is developing immune cell therapies for the treatment of cancer, has entered a collaborative research agreement with TiCARos Co to assess its proprietary CLIP-CAR technology in Cartherics’ induced pluripotent stem cell (iPSC)-derived natural killer (NK) cells.

Published in Health

Subscribe to Newsletter

*  Enter the security code shown: img0

WEBINARS & EVENTS

CYBERSECURITY

PEOPLE MOVES

GUEST ARTICLES

Guest Opinion

ITWIRETV & INTERVIEWS

RESEARCH & CASE STUDIES

Channel News

Comments